Published by Global Banking & Finance Review®
Posted on July 18, 2025
3 min readLast updated: January 22, 2026
Add as preferred source on GoogleThe US has rejected WHO's 2024 health amendments, citing concerns over sovereignty and WHO's expanded role in pandemics.
(Corrects to indicate US rejected 2024 amendments to global health rules, not 2025 pandemic agreement, in headline, paragraphs 1-3, 6-7, 9)
By Ahmed Aboulenein
WASHINGTON (Reuters) -The United States has rejected amendments adopted in 2024 by members of the World Health Organization to its legally binding health rules aimed at improving preparedness for future pandemics following the disjointed global response to COVID-19.
The Department of State and Department of Health and Human Services said in a statement they had transmitted on Friday the official U.S. rejection of the amendments to the International Health Regulations, which were adopted by consensus last year.
The amendments introduced a new category of "pandemic emergency" for the most significant and globally threatening health crises in an effort to shore up the world's defenses against new pathogens.
"Developed without adequate public input, these amendments expand the role of the WHO in public health emergencies, create additional authorities for the WHO for shaping pandemic declarations, and promote WHO's ability to facilitate 'equitable access' of health commodities," the U.S. statement said.
"Terminology throughout the 2024 amendments is vague and broad, risking WHO-coordinated international responses that focus on political issues like solidarity, rather than rapid and effective actions," said the statement, jointly issued by Secretary of State Marco Rubio and Secretary of Health and Human Services Robert F. Kennedy Jr.
Kennedy, who has a long history of sowing doubt about vaccine safety, had slammed the WHO in a video address to the Assembly during its vote on a separate pandemic agreement, saying it had failed to learn from the lessons of the pandemic.
That pact, which was adopted in Geneva in May after three years of negotiations, aims to ensure that drugs, therapeutics and vaccines are globally accessible when the next pandemic hits. It requires participating manufacturers to allocate a target of 20% of their vaccines, medicines and tests to the WHO during a pandemic to ensure poorer countries have access.
U.S. negotiators left discussions about the accord after President Donald Trump began a 12-month process of withdrawing the U.S. - by far the WHO's largest financial backer - from the agency when he took office in January. Its exit means the U.S. would not be bound by the pact.
Kennedy and Rubio said on Friday that their rejection protects U.S. sovereignty. The IHR amendments and the parallel pandemic pact leave health policy to national governments and contain nothing that overrides national sovereignty, however.
(Reporting by Ahmed Aboulenein; Editing by Alexandra Hudson)
The United States rejected amendments adopted in 2024 by the World Health Organization to its legally binding health rules aimed at improving preparedness for future pandemics.
Concerns include that the amendments expand the WHO's role in public health emergencies and introduce vague terminology that could lead to politically driven international responses.
The amendments introduced a new category of 'pandemic emergency' to address significant global health crises and enhance the world's defenses against new pathogens.
US officials argued that the amendments were developed without adequate public input and that they risked undermining US sovereignty in health policy.
The US had previously been the largest financial backer of the WHO but had begun a withdrawal process under President Trump, which influenced its current stance on the amendments.
Explore more articles in the Headlines category
